Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

ABSTRACT:

SUBMITTER: Zhu F 

PROVIDER: S-EPMC10682370 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature